Missing pieces in the Parkinson's disease puzzle, Nature Medicine, vol.23, issue.6, pp.653-61, 2010. ,
DOI : 10.1038/nm.2165
Clinical progression in Parkinson disease and the neurobiology of axons, Annals of Neurology, vol.322, issue.suppl 2, pp.715-740, 2010. ,
DOI : 10.1002/ana.21995
Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain, Neurobiology of Disease, vol.41, issue.2, pp.458-68, 2011. ,
DOI : 10.1016/j.nbd.2010.10.017
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Annals of Neurology, vol.44, issue.4, pp.598-605, 1999. ,
DOI : 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment, Neuroscience, vol.106, issue.3, pp.589-601, 2001. ,
DOI : 10.1016/S0306-4522(01)00295-0
Parkinson's Disease, Neuron, vol.39, issue.6, pp.889-909, 2003. ,
DOI : 10.1016/S0896-6273(03)00568-3
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity., Proceedings of the National Academy of Sciences, vol.82, issue.7, pp.2173-2180, 1985. ,
DOI : 10.1073/pnas.82.7.2173
Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study, Neuroscience, vol.40, issue.1, pp.133-58, 1991. ,
DOI : 10.1016/0306-4522(91)90180-V
Neuronal death: where does the end begin?, Trends in Neurosciences, vol.30, issue.4, pp.159-66, 2007. ,
DOI : 10.1016/j.tins.2007.02.004
Parkinson's disease: the life cycle of the dopamine neuron, Ann N Y Acad Sci, vol.991, pp.1-360, 2003. ,
Signals to promote myelin formation and repair, Nature Reviews Neurology, vol.52, issue.5, pp.276-87, 2010. ,
DOI : 10.1038/nrneurol.2010.37
Remyelination in the CNS: from biology to therapy, Nature Reviews Neuroscience, vol.2, issue.11, pp.839-55, 2008. ,
DOI : 10.1038/nrn2480
The life, death, and replacement of oligodendrocytes in the adult CNS, Journal of Neurochemistry, vol.10, issue.1, pp.1-19, 2008. ,
DOI : 10.1111/j.1471-4159.2008.05570.x
The oligodendrocyte precursor cell in health and disease, Trends in Neurosciences, vol.24, issue.1, pp.39-47, 2001. ,
DOI : 10.1016/S0166-2236(00)01691-X
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord, J Neurosci, vol.20, pp.2218-2246, 2000. ,
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure, Glia, vol.373, issue.4, p.402, 2004. ,
DOI : 10.1002/glia.20015
Glial reactions in Parkinson's disease, Movement Disorders, vol.99, issue.4, pp.474-83, 2008. ,
DOI : 10.1002/mds.21751
Neuroinflammation in Parkinson's disease: a target for neuroprotection?, The Lancet Neurology, vol.8, issue.4, pp.382-97, 2009. ,
DOI : 10.1016/S1474-4422(09)70062-6
Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice, Journal of Neural Transmission, vol.14, issue.Suppl 3, pp.1553-1560, 2007. ,
DOI : 10.1007/s00702-007-0790-9
NACP/??-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson???s disease brains, Acta Neuropathologica, vol.99, issue.1, pp.14-20, 2000. ,
DOI : 10.1007/PL00007400
Protocol for the MPTP mouse model of Parkinson's disease, Nature Protocols, vol.398, issue.1, pp.141-51, 2007. ,
DOI : 10.1038/nprot.2006.342
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics, Proceedings of the National Academy of Sciences, vol.107, issue.46, pp.20021-20027, 2010. ,
DOI : 10.1073/pnas.1008261107
Role of Astrocytes in MPTP Metabolism and Toxicity, Annals of the New York Academy of Sciences, vol.42, issue.1 Neurotoxins a, pp.219-247, 1992. ,
DOI : 10.1016/S0006-291X(88)80432-7
Pathological Evidence of Vacuolar Myelinopathy in a Child Following Vigabatrin Administration, Journal of Child Neurology, vol.49, issue.7, pp.1543-1549, 2009. ,
DOI : 10.1177/0883073809348796
Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat, Annals of Neurology, vol.23, issue.1, pp.46-55, 1998. ,
DOI : 10.1002/ana.410430111
Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material, Acta Neuropathologica, vol.194, issue.4, pp.352-60, 1992. ,
DOI : 10.1007/BF00713525
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha -, beta -, and gamma -synuclein, Proceedings of the National Academy of Sciences, vol.96, issue.23 ,
DOI : 10.1073/pnas.96.23.13450
Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons, Journal of Neuroscience Research, vol.148, issue.1, pp.126-161, 2000. ,
DOI : 10.1002/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L
Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum, Brain Research, vol.225, issue.2, pp.373-85, 1981. ,
DOI : 10.1016/0006-8993(81)90843-X
Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey, The Journal of Comparative Neurology, vol.575, issue.1, pp.1-19, 1994. ,
DOI : 10.1002/cne.903440102
Immunocytochemical localization of tyrosine hydroxylase in the human striatum: A postmortem ultrastructural study, The Journal of Comparative Neurology, vol.94, issue.1, pp.52-62, 1998. ,
DOI : 10.1002/(SICI)1096-9861(19980105)390:1<52::AID-CNE5>3.0.CO;2-P
Modulation of Striatal Projection Systems by Dopamine, Annual Review of Neuroscience, vol.34, issue.1, pp.441-66, 2011. ,
DOI : 10.1146/annurev-neuro-061010-113641
Axon-Glial Signaling and the Glial Support of Axon Function, Annual Review of Neuroscience, vol.31, issue.1, pp.535-61, 2008. ,
DOI : 10.1146/annurev.neuro.30.051606.094309
Axonal Signals and Oligodendrocyte Differentiation, Neurochemical Research, vol.29, issue.5, pp.979-88, 2004. ,
DOI : 10.1023/B:NERE.0000021242.12455.75
Negative regulation of myelination: Relevance for development, injury, and demyelinating disease, Glia, vol.152, issue.14, pp.1552-65, 2008. ,
DOI : 10.1002/glia.20761
Negative regulation of central nervous system myelination by polysialylatedneural cell adhesion molecule, Proc Natl Acad Sci, vol.20, pp.7585-90, 2000. ,
Transcription of myelin basic protein promoted by regulatory elements in the proximal 5??? sequence requires myelinogenesis, Multiple Sclerosis Journal, vol.16, issue.3, pp.125-157, 1996. ,
DOI : 10.1177/135245859600200302
Characterization of oligodendrocyte lineage precursor cells in the mouse cerebral cortex: a confocal microscopy approach to demyelinating diseases, Ital J Anat Embryol, vol.115, pp.95-102, 2010. ,
The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J Neurosci, vol.22, pp.2451-2460, 2002. ,
Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition, Glia, vol.12, issue.1, pp.39-48, 1996. ,
DOI : 10.1002/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.0.CO;2-Z